WANDA L. SANTIAGO-PEREZ RPH
Prescription History 1497048482
Pharmacist in Vega Baja, PR

NPI Status: Active since May 24, 2011

Contact Information

210 PASEO TRIO VEGABAJENO
TORREVISTA 995
VEGA BAJA, PR
ZIP 00693
Phone: (787) 855-3004
Fax: (787) 855-3301

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for WANDA L. SANTIAGO-PEREZ RPH, an active Pharmacist specialist practicing in Vega Baja, PR. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 160 documented patient claims. Among these therapy options, the most frequently utilized medication is Shingrix, which accounts for 110 claims alone.

Medication Index

No matching medications currently found on file.

Abrysvo

Generic Formulation: Rsv Vacc, Pref A And Pref B/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 13
PR State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$324.67

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Boostrix Tdap

Generic Formulation: Diphth,pertuss(Acell),tet VacSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 37
30-Day Fills 37.0
Days Supply 37
PR State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills48.7
Peer Average Days Supply86
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,505.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$67.72

State Avg Cost Per Claim

$62.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 110
30-Day Fills 110.0
Days Supply 197
PR State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills27.0
Peer Average Days Supply78
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 323.1% higher than the standard regional baseline profile for PR. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $22,640.62 across this reporting matrix range.

Provider Avg Cost Per Claim

$205.82

State Avg Cost Per Claim

$191.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like WANDA L. SANTIAGO-PEREZ RPH provides transparency into local medical care patterns within Vega Baja, PR.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.